Pharmaceutical composition of containing puerarin and leaves of hawthorn

A composition and technology of hawthorn leaves are applied in the field of medicine to achieve the effects of reducing cardiac preload, stabilizing various indicators, and uniform and stable drug quality

Inactive Publication Date: 2007-10-10
JIANGYIN TIANJIANG PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there is no report on the use of puerarin and hawthorn leaves for the preparation of drugs for the treatment of cardiovascular and cerebrovascular diseases through the interaction and compatibility of prescriptions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition of containing puerarin and leaves of hawthorn

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0131] The preparation of embodiment 1 hawthorn leaf total flavonoids

[0132] Take hawthorn leaves, dry and crush them, add 60% ethanol to reflux and extract three times, each time for 1 hour, add 8 times the amount of ethanol, combine the extracts, filter, and recover the ethanol from the filtrate under reduced pressure until the relative density is 1.04-1.06 (60°C) After diluting with an equal amount of water, shake and extract with 1 / 2 times the amount of petroleum ether (60-90°C), discard the petroleum ether solution, shake and extract the aqueous layer with ethyl acetate, and depressurize the extract Recover ethyl acetate and concentrate to dryness, then add appropriate amount of water to dissolve, add to the treated polyamide column (30-60 mesh, wet packing with ethanol, pre-wash with appropriate amount of ethanol, then wash with water until no alcohol smell, set aside ), first eluted with 2 times column volume of water, discarded the water washing solution, and then el...

Embodiment 2

[0147] Embodiment 2: Preparation of GS composition powder injection

[0148] prescription:

[0149] Hawthorn leaves total flavonoids 47.6g (equivalent to about 2000g hawthorn leaves)

[0150] Puerarin 200g

[0151] Polysorbate 80 80g

[0152] Mannitol 300g

[0153] Sorbitol 50g

[0154] Add sterile water for injection to 3000ml

[0155] A total of 1000 sticks were prepared

[0156] Preparation Process:

[0157] (1) Firstly, the containers used for liquid preparation, antibiotic glass bottles, rubber stoppers, etc. are aseptically treated.

[0158] (2) Weigh the raw and auxiliary materials according to the prescription quantity.

[0159] (3) Add the total flavonoids of hawthorn leaves into 30% sterile water for injection and heat to dissolve completely. Add mannitol and sorbitol to 30% sterile water for injection, heat and stir to dissolve completely, add polysorbate 80 to 20% sterile water for injection to make an aqueous solution, add puerarin to heat and dissolve, c...

Embodiment 3

[0167] Embodiment 3: Preparation of GS composition aqueous injection

[0168] prescription:

[0169] Hawthorn leaves total flavonoids 47.6g (equivalent to about 2000g hawthorn leaves)

[0170] Puerarin 200g

[0171] Macrogol 400 200ml

[0172] Ethanol 200ml

[0173] Add water for injection to 2000ml

[0174] A total of 1000 sticks were prepared

[0175] Preparation Process:

[0176] (1) Dispose of the pipes and containers used for liquid preparation one day in advance, and rinse them with fresh water for injection before use.

[0177] (2) Mix ethanol with an equal amount of water, add total flavonoids of hawthorn leaves to dissolve; dissolve polyethylene glycol 400 with 50% water, and then add puerarin and stir to dissolve.

[0178] (3) Combine the above two solutions, and add water for injection to the full amount.

[0179] (4) Add activated carbon for needles with a dosing volume of 0.1%, heat and stir for 15 minutes.

[0180] (5) Decarburization by sand filter rod ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A medical composition in the form of injection or orally taken solid or liquid for treating coronary heart disease, angina pectoris, hypertension, cerebrovascular disease, hemicrania, diabetes, etc is proportionally prepared from kakonein and hawthorn leaf flavone.

Description

1. Technical field [0001] The invention relates to a pharmaceutical composition mainly made of puerarin and hawthorn leaves or total flavonoids of hawthorn leaves, a preparation method and application thereof, and belongs to the technical field of medicines. 2. Background technology [0002] Cardiovascular and cerebrovascular diseases are the most important diseases that endanger human life and health, and are the number one killer of death. They are characterized by high morbidity, high mortality, high disability and high recurrence rate. According to relevant survey reports, there are more than 3 million patients who die from cardiovascular and cerebrovascular diseases in my country every year, accounting for 50% of the total number of deaths in my country each year, and 75% of those who survived the disease also lost their ability to work to varying degrees, and 4% Heavy disabled. In particular, the age of its onset and death is getting younger, making how to effectively ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/734A61P9/10A61P9/12A61P7/02A61P3/06A61K31/7048
Inventor 黄振华
Owner JIANGYIN TIANJIANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap